Paul Vulto

This study develops a scalable microvascular network-on-chip system that supports 8-week perfusion, revealing maturation-dependent toxicity responses to drugs.

This study evaluates drug responses in a patient-derived HCC chip model, showing varying effects on tumor cells and microenvironment factors like vasculature and cytokines.

This paper develops a scalable in vitro liver model with microvascular components to study disease and drug responses, showing it can model steatosis and fibrosis.